Q2 2019 Biomarin Pharmaceutical Inc Earnings Call Transcript
And good afternoon, and welcome to the BioMarin second quarter investor update. My name is Altecia, and I will be facilitating the audio portion of today's interactive broadcast. (Operator Instructions)
At this time, I would now like to turn this show over to Traci, Vice President of Investor Relations.
Thank you, Altecia. Thanks, everyone, for joining us today.
(technical difficulty)
Chairman and Chief Executive Officer; Hank Fuchs, President of Worldwide Research and Development; Dan Spiegelman, Executive Vice President and Chief Financial Officer; Jeff Ajer, Executive Vice President, Chief Commercial Officer; and Robert Baffi, President of Global Manufacturing and Technical Operations. Based on positive feedback from our last quarterly call, we intend to keep this call to an hour in length. If we do not get to your questions, please send an e-mail or give me a call and we'll get right back to you. Thank you for understanding. Now, I'd like to turn the call over to BioMarin's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
